First Page | Document Content | |
---|---|---|
Fertility In vitro fertilisation Preimplantation genetic diagnosis Ovarian hyperstimulation Transvaginal oocyte retrieval Human chorionic gonadotropin Assisted reproductive technology Gonadotropin-releasing hormone antagonist Gonadotropin-releasing hormone agonist Fertility medicine Human reproduction Medicine | Experimental research Comparisons of the effects of long-acting andAdd to Reading ListSource URL: www.ncbi.nlm.nih.govDownload Document from Source WebsiteFile Size: 456,56 KBShare Document on Facebook |
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.DocID: 16voX - View Document | |
IVF/GIFT Elonva® applications Purpose of this form Filling in this formDocID: UsX0 - View Document | |
SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: JtWT - View Document | |
SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: ISkM - View Document | |
SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: IJbr - View Document |